5-Cyclopropylisoxazole-4-carboxylic acid - CAS 124845-04-1
Catalog: |
BB006002 |
Product Name: |
5-Cyclopropylisoxazole-4-carboxylic acid |
CAS: |
124845-04-1 |
Synonyms: |
5-cyclopropyl-1,2-oxazole-4-carboxylic acid |
IUPAC Name: | 5-cyclopropyl-1,2-oxazole-4-carboxylic acid |
Description: | 5-Cyclopropylisoxazole-4-carboxylic acid (CAS# 124845-04-1) is a useful research chemical. |
Molecular Weight: | 153.14 |
Molecular Formula: | C7H7NO3 |
Canonical SMILES: | C1CC1C2=C(C=NO2)C(=O)O |
InChI: | InChI=1S/C7H7NO3/c9-7(10)5-3-8-11-6(5)4-1-2-4/h3-4H,1-2H2,(H,9,10) |
InChI Key: | KIJMAOMSRMPYIY-UHFFFAOYSA-N |
Boiling Point: | 317.6 °C at 760 mmHg |
Melting Point: | 161-165 °C (lit.) |
Purity: | 95 % |
Density: | 1.445 g/cm3 |
Appearance: | Solid |
MDL: | MFCD06798100 |
LogP: | 1.25020 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P301+P312, P330, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2020241414-A1 | Resist composition and patterning process | 20190129 |
US-2020192222-A1 | Resist composition and patterning process | 20181218 |
AU-2018320672-A1 | Quinoxaline derivatives as adenosine receptor antagonists | 20170821 |
AU-2018320673-A1 | Bezimidazole derivatives as adenosine receptor antagonists | 20170821 |
CA-3073333-A1 | Bezimidazole derivatives as adenosine receptor antagonists | 20170821 |
Complexity: | 179 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 153.042593085 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 153.042593085 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 63.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Isoxazoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS